Phosphodiesterase-4 inhibitors for the treatment of inflammatory diseases

H Li, J Zuo, W Tang - Frontiers in pharmacology, 2018 - frontiersin.org
Phosphodiesterase-4 (PDE4), mainly present in immune cells, epithelial cells, and brain
cells, manifests as an intracellular non-receptor enzyme that modulates inflammation and …

PDE4 inhibitors: Profiling hits through the multitude of structural classes

J Jin, F Mazzacuva, L Crocetti, MP Giovannoni… - International Journal of …, 2023 - mdpi.com
Cyclic nucleotide phosphodiesterases 4 (PDE4) are a family of enzymes which specifically
promote the hydrolysis and degradation of cAMP. The inhibition of PDE4 enzymes has been …

Inhibition of phosphodiesterase‐4 attenuates murine ulcerative colitis through interference with mucosal immunity

H Li, C Fan, C Feng, Y Wu, H Lu, P He… - British journal of …, 2019 - Wiley Online Library
Background and Purpose Ulcerative colitis (UC) is an aetiologically refractory inflammatory
disease, accompanied by dysfunction of the epithelial barrier and intestinal inflammation …

Vitronectin Destroyed Intestinal Epithelial Cell Differentiation through Activation of PDE4‐Mediated Ferroptosis in Inflammatory Bowel Disease

W Pan, L Xiang, X Liang, W Du, J Zhao… - Mediators of …, 2023 - Wiley Online Library
Objective. Vitronectin (VTN) has been reported to trigger cell pyroptosis to aggravate
inflammation in our previous study. However, the function of VTN in inflammatory bowel …

Cyclic adenosine 3', 5'-monophosphate (cAMP) signaling is a crucial therapeutic target for ulcerative colitis

H Cheng, Y Yang, J Hu, L Chen, M Yuan, H Du, Z Xu… - Life Sciences, 2024 - Elsevier
The pathogenesis of ulcerative colitis (UC), a chronic intestine inflammatory disease
primarily affecting adolescents, remains uncertain. Contemporary studies suggest that a …

Discovery of novel PDE4 inhibitors targeting the M-pocket from natural mangostanin with improved safety for the treatment of Inflammatory Bowel Diseases

H Liu, Q Wang, Y Huang, J Deng, X Xie, J Zhu… - European Journal of …, 2022 - Elsevier
Abstract Inflammatory Bowel Diseases (IBDs) are chronic disorders with iterative intestinal
mucosal inflammation which remain unmet medical needs. PDE4 inhibitors were reported to …

Long‐term clearance of severe plaque psoriasis with oral roflumilast.

M Gyldenløve, H Meteran… - Journal of the …, 2023 - search.ebscohost.com
If the observed long-term efficacy and safety are confirmed in clinical trials, oral roflumilast
may represent a novel and favourable treatment option for patients with plaque psoriasis …

Roflumilast ameliorates cognitive deficits in a mouse model of amyloidogenesis and tauopathy: Involvement of nitric oxide status, Aβ extrusion transporter ABCB1, and …

NH Ashour, DM El-Tanbouly, NS El Sayed… - Progress in Neuro …, 2021 - Elsevier
The biological cascade of second messenger–cyclic adenosine monophosphate (cAMP)–as
a molecular mechanism implicated in memory and learning regulation has captured the …

Hypericum sampsonii attenuates inflammation in mice with ulcerative colitis via regulation of PDE4/PKA/CREB signaling pathway

Y Lin, J Su, M Wang, Y Li, Z Zhao, Z Sun - Journal of Ethnopharmacology, 2022 - Elsevier
Abstract Ethnopharmacological relevance Hypericum sampsonii Hance (Yuanbaocao), a
traditional herbal medicine with various pharmacological properties, is traditionally used to …

[HTML][HTML] Qingchi San (青赤散) treats ulcerative colitis in mice by inhibiting the nuclear factor-kappa B signaling pathway and Nucleotide-binding oligomerization …

Z Zhenghua, JI Jianbin, W Hongxia… - Journal of Traditional …, 2023 - ncbi.nlm.nih.gov
OBJECTIVE: To investigate the efficacy of Qingchi San (青赤散, QCS), a preparation of
Traditional Chinese Medicine, on ulcerative colitis (UC) in mice by inhibiting the …